News
Filter
-
LifeArc funds innovative rare liver disease clinical trial
Read more: LifeArc funds innovative rare liver disease clinical trial -
New smartphone app offers hope in the fight against neglected tropical diseases
Read more: New smartphone app offers hope in the fight against neglected tropical diseases -
Bronchiectasis: an overlooked lung condition with untapped commercial and research potential
Read more: Bronchiectasis: an overlooked lung condition with untapped commercial and research potential -
Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists
Read more: Cambridge Science Centre opens new facility that will educate and inspire the next generation of scientists -
Research shows potential ‘life-transforming’ mole reversal therapy in rare condition
Read more: Research shows potential ‘life-transforming’ mole reversal therapy in rare condition -
LifeArc announces research funding boost to address dengue fever amid growing global health threat
Read more: LifeArc announces research funding boost to address dengue fever amid growing global health threat -
LifeArc co-funds a new blood test that could prevent sudden child deaths caused by hereditary heart condition
Read more: LifeArc co-funds a new blood test that could prevent sudden child deaths caused by hereditary heart condition -
The new LifeArc identity: More than just a fresh coat of paint
Read more: The new LifeArc identity: More than just a fresh coat of paint -
New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development
Read more: New partnership aims to develop clinical tools for motor neuron disease prognosis, monitoring, and drug development -
Hope for children with cancer: LifeArc and CureSearch fund research into whether a modified cold sore virus, combined with a vaccine, could cure brain cancer
Read more: Hope for children with cancer: LifeArc and CureSearch fund research into whether a modified cold sore virus, combined with a vaccine, could cure brain cancer -
LifeArc backs new report that warns UK business R&D investment has ‘stagnated’ and calls for improved investment incentives
Read more: LifeArc backs new report that warns UK business R&D investment has ‘stagnated’ and calls for improved investment incentives -
LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
Read more: LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation